REPLIGEN CORP
10-K, EX-23, 2000-06-23
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: REPLIGEN CORP, 10-K, EX-21, 2000-06-23
Next: REPLIGEN CORP, 10-K, EX-27.1, 2000-06-23



<PAGE>

                                                                      EXHIBIT 23


                    CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

         As independent public accountants, we hereby consent to incorporation
     by reference in this Form 10-K of our reports dated May 25, 2000 included
     in or made part of this Form 10-K, into the Company's previously filed
     Registration Statement Nos. 33-62796, 333-30383, 333-57951, 333-76005,
     333-79611, 333-95641, 333-31728, 333-35056 and 333-36280. It should be
     noted that we have not audited any financial statements of the company
     subsequent to March 31, 2000 or performed any audit procedures subsequent
     to the date of our report.


                                                     /s/ ARTHUR ANDERSEN LLP
                                                   -----------------------------
                                                         ARTHUR ANDERSEN LLP



Boston, Massachusetts
June 23, 2000




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission